Thurston Springer Miller Herd & Titak’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37K Sell
776
-58
-7% -$2.69K 0.01% 528
2026
Q1
$36.5K Sell
834
-394
-32% -$18K 0.02% 613
2025
Q4
$54.4K Buy
1,228
+1,095
+823% +$47.2K 0.02% 464
2025
Q3
$5.61K Sell
133
-7,789
-98% -$314K 0.01% 405
2025
Q2
$290K Buy
7,922
+2,224
+39% +$82.6K 0.04% 315
2025
Q1
$217K Buy
5,698
+1,612
+39% +$60K 0.04% 316
2024
Q4
$155K Sell
4,086
-1,378
-25% -$55.1K 0.03% 306
2024
Q3
$222K Buy
5,464
+414
+8% +$15.7K 0.06% 278
2024
Q2
$173K Buy
+5,050
New +$159K 0.05% 327

Other funds holding OHI

Thurston Springer Miller Herd & Titak's OHI Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak reduced its Omega Healthcare (OHI) stake by 7% in Q2 2026, selling an estimated $2.69K and leaving 776 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #528.

Thurston Springer Miller Herd & Titak first reported a position in OHI in Q2 2024 and has held it in 9 quarters since. The position peaked at $290K in Q2 2025. 268 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 776 shares of Omega Healthcare worth $37K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak sold 58 Omega Healthcare shares in Q2 2026, an estimated $2.69K.
  • Omega Healthcare made up 0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #528 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Omega Healthcare in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Omega Healthcare position peaked at $290K in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.